Jaguar health announces receipt by napo therapeutics of small and medium enterprise (sme) designation from the european medicines agency

Sme status is an important designation for italy-based napo therapeutics' rare/orphan disease business model san francisco, ca and milan, italy / accesswire / february 15, 2022 / jaguar health (nasdaq:jagx) and napo therapeutics s.p.a., an italian corporation established by jaguar health in milan, italy, today announced that napo therapeutics has been granted small and medium enterprise (sme) designation by the european medicines agency (ema).
JAGX Ratings Summary
JAGX Quant Ranking